Analyst expects tense competition following Demant's improved outlook

Intensifying product competition among the Big Three hearing aid manufacturers could accelerate innovation and affect pricing and product availability for clinics and dispensers.

WSA will not renew major contract with US managed care client

The loss of a major managed care contract by WSA illustrates how dependent hearing care providers can be on third-party payer relationships, with single contract changes capable of materially affecting company revenues.

Demant CEO on upward revision: “There is strong momentum in the business”

Demant's upward financial revision signals continued market expansion in the hearing industry, which may influence competitive dynamics, pricing, and product investment across the sector.

Alle Funktionen der Signia App im (aktualisierten) Überblick | Signia Hörgeräte

Mit der Signia App steuern Sie Ihre Signia Hörgeräte dezent und bequem über Ihr Smartphone. Einstellungen mit Hilfe des KI-gestützten Signia Assistant ändern, Lautstärke einstellen, Programme auswählen und sogar Schritte zählen: Die App ist Ihr täglicher Begleiter....

NEW Oticon Reveal Hearing Aids: Better Than Intent?

Oticon has officially launched the new Oticon Reveal hearing aids, but are they actually better than Oticon Intent, and should existing Intent users upgrade? In this launch-day breakdown, I take a detailed look at Oticon Reveal and the technology behind what Oticon describes as...

Audiology’s journey into the unknown – with Starkey’s Dave Fabry

Reframing enduring patient priorities as a compass for future R&D and fitting practices keeps audiologists aligned with what users actually value rather than what technology alone can offer.

The Cutest Mascot For Kids With Cochlear Implants

Happy Birthday, Mellie! Celebrating on World Elephant Day (of course 🐘) with all her little friends. ❤️ Has Mellie been part of your hearing loss journey? Tell her in the comments!

Demant upgrades outlook and launches new product initiative

Demant's upgraded growth forecast signals continued market expansion in hearing healthcare, which could influence competitive pricing, product availability, and clinic partnership strategies.

FDA clears Samsung Galaxy Buds Hearing Aid feature using NAL-NL2 for fitting

No immediate practice change is required; however, clinicians should anticipate patient inquiries about Samsung OTC hearing aids and be prepared to discuss their appropriate candidacy (mild-to-moderate perceived loss only) relative to professionally fitted devices.

Samsung Galaxy Buds Gain FDA-Cleared OTC Hearing Aid Feature

Samsung's FDA clearance adds a major consumer electronics brand to the growing OTC hearing aid market, increasing competitive pressure on traditional hearing aid manufacturers and potentially lowering the barrier to amplification for millions of people with mild-to-moderate...

What Makes Us Mad About Our Hearing Loss?

First-person patient narratives like this serve as a reminder that hearing technology does not fully resolve the social and emotional toll of hearing loss, underscoring the importance of counseling and psychosocial support in audiologic care.

The Sound Sister's Chat: Why Good Friends Are Essential

The #1 Thing People Notice About Starkey Omega AI

What do patients and hearing care professionals value most in a hearing aid? In this video, patients and professionals share the features they believe matter most in Starkey Omega AI....

The Biggest Hearing Aid Myth Is Holding People Back

Do hearing aids make you look old? It's one of the most common misconceptions hearing care professionals hear every day. Many people delay addressing hearing loss because they associate hearing aids with aging or believe they can simply "wait a little longer." Unfortunately,...

Fennec Pharmaceuticals Reports 78% Revenue Jump as Pedmark Demand Reaches Record High

Record adoption of the only FDA-approved otoprotective agent for pediatric cisplatin patients signals growing integration of hearing-preservation protocols in pediatric oncology, which has downstream implications for audiology referral volume and counseling practices.

ADA Awards Inaugural Audiology Practice Accreditation to North Carolina Clinic

The launch of the ADA's inaugural Practice Accreditation marks a significant step toward formalizing quality standards for independent audiology clinics, potentially shaping how the profession benchmarks and differentiates practice excellence.

Oticon reveals the Oticon Reveal (and yes, it has Auracast)

The Oticon Reveal's claimed Dual AI architecture and native Auracast support represent the latest escalation in AI-powered hearing aid feature competition, which will directly shape patient counselling and product selection conversations.

Samsung Galaxy Buds Hearing Aid Feature Receives FDA Clearance

Clinicians should be aware that patients with self-perceived mild-to-moderate hearing loss may present having already adopted Galaxy Buds as OTC hearing aids; counselling on appropriate use, limitations, and when to seek a formal audiological evaluation remains important.

Wisconsin audiologists to get first-hand Auracast demo at State Conference

Live demonstrations of Auracast at state audiology conferences accelerate real-world familiarity with the technology among dispensers and advocates who will counsel patients on it.

EUHA 2026: Young creators wanted to help document Hanover Congress

Engaging the next generation of content creators in audiology events could broaden public awareness and professional dialogue around hearing health.

From Hearing Loss to a Cochlear Implant—Ewa’s Journey

► Learn more about https://www.medel.com/hearing-solutions/cochlear-implants *From Hearing Loss to a Cochlear Implant—Ewa’s Journey* Meet Ewa, the mother of a cochlear implant user and Hearpeers Mentor from Poland....

When Accessibility Goes Mainstream: Captions, AI and What Comes Next

Brian Taylor interviews InnoCaption CEO Paul Lee on the evolution of AI-powered captioned communication technology and the challenges of building reliable accessible tools for people with hearing loss.

Skylark Bio Doses First Patient in Gene Therapy Trial for GJB2-Related Hearing Loss

If proven safe and effective, gene therapy targeting GJB2 mutations could offer the first disease-modifying treatment for one of the most common causes of inherited hearing loss, fundamentally reshaping the audiology care pathway.

Unitron roadshow launches Moxi S-RX rechargeable RIC with world first denoising chip

Chipset-level noise processing innovation, if independently validated, could represent a meaningful step forward in hearing aid signal processing for patients struggling in noisy environments.

Amplifon heads to GN Hearing deal trumpeting Q2 two-year organic growth high and profitability acceleration

If regulators approve the Amplifon–GN Hearing retail acquisition, it would significantly concentrate ownership of hearing care retail networks, potentially affecting competition, pricing, and independent clinic dynamics across multiple markets.

What I Told a Room Full of Hearing Scientists

Bridging the gap between patient-lived experience and hearing research priorities can lead to studies that are more meaningful and outcomes that patients actually care about.

How Hearing Works - 3D Animation (NO AI!)

How Hearing Works - 3D Animation (NO AI!) Most of us take our hearing for granted. However as an audiologist who helps individuals with hearing loss daily, understanding the complex and delicate system that helps us hear the world around us is of utmost importance....

Ampicillin/ceftriaxone vs. β-lactam/aminoglycoside combination therapy for Enterococcus faecalis infective endocarditis: a systematic review and meta-analysis

Audiologists working in hospital or oncology settings should be aware of this meta-analysis: if ampicillin/ceftriaxone is shown to be equally or more effective than aminoglycoside-based regimens, it supports a shift away from ototoxic antibiotics — potentially reducing referrals...